参考文献/References:
[1] Müller HL. Craniopharyngioma[J].Endocr Rev,2014,35(3):513-543. DOI:10.1210/er.2013-1115.
[2] Müller HL. Craniopharyngioma: long-term consequences of a chronic disease[J].Expert Rev Neurother,2015,15(11):1241-1244. DOI:10.1586/14737175.2015.1100078.
[3] Haliloglu B, Bereket A. Hypothalamic obesity in children: pathophysiology to clinical management[J].J Pediatr Endocrinol Metab,2015,28(5-6):503-513. DOI:10.1515/jpem-2014-0512.
[4] Müller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity[J].Curr Opin Endocrinol Diabetes Obes,2016,23(1):81-89. DOI:10.1097/MED.0000000000000214.
[5] Elowe-Gruau E, Beltrand J, Brauner R,et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity[J].J Clin Endocrinol Metab,2013,98(6):2376-2382. DOI:10.1210/jc.2012-3928.
[6] Daubenbüchel AM, Müller HL. Neuroendocrine disorders in pediatric craniopharyngioma patients[J].J Clin Med,2015,4(3):389-413.DOI:10.3390/jcm4030389.
[7] Erfurth EM. Endocrine aspects and sequel in patients with craniopharyngioma[J].J Pediatr Endocrinol Metab,2015,28(1-2):19-26. DOI:10.1515/jpem-2014-0419.
[8] Zheng X, Li S, Zhang WH,et al. Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor[J].Diabetes Metab Syndr Obes,2015,8:357-361. DOI:10.2147/DMSO.S86319.
[9] Piguel X, Abraham P, Bouhours-Nouet N,et al. Impaired aerobic exercise adaptation in children and adolescents with craniopharyngioma is associated with hypothalamic involvement[J].Eur J Endocrinol,2012,166(2):215-222. DOI:10.1530/EJE-11-0742.
[10] Elfers CT, Roth CL. Effects of methylphenidate on weight gain and food intake in hypothalamic obesity[J].Front Endocrinol(Lausanne),2011,2:78. DOI:10.3389/fendo.2011.00078.
[11] Aversa T, Valenzise M, Zirilli G,et al. Key-role of thyrotropin deficiency in disclosing craniopharyngioma diagnosis in ashort girl with Hashimoto's thyroiditis[J].Minerva Pediatr,2016,68(2):152-154.
[12] Ghamari-Langroudi M, Cone RD. Shining a light on energy homeostasis[J].Cell Metab,2011,13(3):235-236. DOI:10.1016/j.cmet.2011.02.007.
[13] Iughetti L, Bruzzi P. Obesity and craniopharyngioma[J]. Ital J Pediatr,2011,37:38. DOI:10.1186/1824-7288-37-38. DOI:10.1186/1824-7288-37-38.
[14] Lustig RH. Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment[J]. Front Endocrinol(Lausanne),2011,2:60.
[15] Roemmler-Zehrer J, Geigenberger V, Störmann S, et al. Food intake regulating hormones in adult craniopharyngioma patients[J].Eur J Endocrinol,2014,170(4):627-635. DOI:10.1530/EJE-13-0832.
[16] Kalina MA, Wilczek M, Kalina-Faska B,et al. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience[J].J Pediatr Endocrinol Metab,2015,28(1-2):45-51. DOI:10.1515/jpem-2014-0425.
[17] Wijnen M, Olsson DS, van den Heuvel-Eibrink MM,et al. Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamicobesity: a matched case-control study with 2 years of follow-up[J].Int J Obes(Lond),2017,41(2):210-216. DOI:10.1038/ijo.2016.195.
[18] Zoicas F, Droste M, Mayr B,et al. GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases[J].Eur J Endocrinol,2013,168(5):699-706. DOI:10.1530/EJE-12-0997.
[19] Kalina MA, Wilczek M, Kalina-Faska B,et al. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience[J].J Pediatr Endocrinol Metab,2015,28(1-2):45-51. DOI:10.1515/jpem-2014-0425.
[20] Mendonça FM, de Sousa FR, Barbosa AL,et al. Metabolic syndrome and risk of cancer: which link [J]. Metabolism,2015,64(2):182-189. DOI:10.1016/j.metabol.2014.10.008.
[21] Braun S, Bitton-Worms K, LeRoith D. The link between the metabolic syndrome and cancer[J].Int J Biol Sci,2011,7(7):1003-1015.
相似文献/References:
[1]吴蔚,杨叶虹,李益明.下丘脑性肥胖临床研究进展[J].国际内分泌代谢杂志,2014,(01):32.[doi:10.3760/cma.j.issn.1673-4157.2014.01.009]
Wu Wei,Yang Yehong,Li Yiming.Clinical progress in hypothalamic obesity[J].International Journal of Endocrinology and Metabolism,2014,(05):32.[doi:10.3760/cma.j.issn.1673-4157.2014.01.009]
[2]余红,何庆.欧洲内分泌学会生长激素替代治疗安全性的共识解读——颅咽管瘤术后[J].国际内分泌代谢杂志,2023,43(03):274.[doi:10.3760/cma.j.cn121383-20230504-05006]
Yu Hong,He Qing..Interpretation of the European Endocrine Society Consensus on the safety of growth hormone replacement therapy-Postoperative craniopharyngioma[J].International Journal of Endocrinology and Metabolism,2023,43(05):274.[doi:10.3760/cma.j.cn121383-20230504-05006]
[3]申丹丹 贾红蔚 刘铭 何庆 郑方遒.颅咽管瘤术后垂体功能减退患者糖代谢异常危险因素研究[J].国际内分泌代谢杂志,2022,42(04):293.[doi:10.3760/cma.j.cn121383-20210104-01006]
Shen Dandan,Jia Hongwei,Liu Ming,et al.Study on the risk factors of abnormal glucose metabolism in patients with hypopituitarism after craniopharyngioma surgery[J].International Journal of Endocrinology and Metabolism,2022,42(05):293.[doi:10.3760/cma.j.cn121383-20210104-01006]